{"database": "openregs", "table": "dockets", "rows": [["CMS-2023-0146", "CMS", "Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer\u2019s Disease (CMS\u201310865)", "Nonrulemaking", "2023-09-07T15:04:25Z", "0b00006485f53618"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["CMS-2023-0146"], "units": {}, "query_ms": 0.34959602635353804, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}